El EMCDDA brinda datos sobre las implicancias de la pandemia para la reducción de daños y los proveedores de tratamiento, desde el manejo de recortes de personal hasta el uso de plataformas móviles o virtuales. Más información, en inglés, está disponible abajo.

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug services in Europe, the European Monitoring Centre for Drugs and Drug Addiction instigated a mixed-method trendspotter study to provide a snapshot of the current situation. This exercise provides a rapid assessment of the state of play in respect to the impact of COVID-19 on service provision and help-seeking behaviour among people who use drugs.